{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:11Z","timestamp":1789154411068,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.7759\/cureus.79534","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:02:59Z","timestamp":1740380579000},"source":"Crossref","is-referenced-by-count":3,"title":["Life-Threatening Haemorrhagic Enterocolitis: A Rare Complication of Chemotherapy With Cyclophosphamide"],"prefix":"10.7759","author":[{"given":"Gousmahammad","family":"Myageri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith Kumar","family":"AK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijith","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yathish","family":"GC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesha Gupta","family":"KV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13341","article-title":"Hospitalizations due to systemic connective tissue diseases: secular trends and regional disparities in Sweden, 1998-2016","volume":"21","author":"Kiadaliri AA","year":"2018","unstructured":"Kiadaliri AA, Mohammad AJ, Englund M. Hospitalizations due to systemic connective tissue diseases: secular trends and regional disparities in Sweden, 1998-2016. Int J Rheum Dis. 2018, 21:1900-6. 10.1111\/1756-185X.13341","journal-title":"Int J Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sj\u00f6gren's syndrome (secondary Sj\u00f6gren's syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"Alani H","year":"2018","unstructured":"Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sj\u00f6gren's syndrome (secondary Sj\u00f6gren's syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018, 47:141-54. 10.1080\/03009742.2017.1324909","journal-title":"Scand J Rheumatol"},{"key":"ref3","article-title":"Diagnostic (classification) criteria and treatment guidelines of collagen-vascular diseases: hos to use and cautions on applying them for general physicians. Topics: VII. Sj\u00f6gren syndrome [Article in Japanese]","volume":"104","author":"Kaneko Y","year":"2015","unstructured":"Kaneko Y. Diagnostic (classification) criteria and treatment guidelines of collagen-vascular diseases: hos to use and cautions on applying them for general physicians. Topics: VII. Sj\u00f6gren syndrome [Article in Japanese]. J Jpn Soc Intern Med. 2015, 104:2149-56.","journal-title":"J Jpn Soc Intern Med"},{"key":"ref4","article-title":"Phenotyping Sj\u00f6gren's syndrome: towards a personalised management of the disease","volume":"36 Suppl 112","author":"Brito-Zer\u00f3n P","year":"2018","unstructured":"Brito-Zer\u00f3n P, Retamozo S, Ramos-Casals M. Phenotyping Sj\u00f6gren's syndrome: towards a personalised management of the disease. Clin Exp Rheumatol. 2018, 36 Suppl 112:198-209.","journal-title":"Clin Exp Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02589-1","article-title":"Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro","volume":"93","author":"Mills KA","year":"2019","unstructured":"Mills KA, Chess-Williams R, McDermott C. Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde's contribution to urothelial dysfunction in vitro. Arch Toxicol. 2019, 93:3291-303. 10.1007\/s00204-019-02589-1","journal-title":"Arch Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz A","year":"2007","unstructured":"Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 2007, 23:303-12. 10.1007\/s10565-006-0078-0","journal-title":"Cell Biol Toxicol"},{"key":"ref7","article-title":"Risk factors and prophylaxis of Pneumocystis jirovecii pneumonia in HIV-negative patients [Article in French]","volume":"14","author":"Chatelanat O","year":"2018","unstructured":"Chatelanat O, Van Delden C, Adler D, Guerne PA, Nendaz M, Serratrice J. Risk factors and prophylaxis of Pneumocystis jirovecii pneumonia in HIV-negative patients [Article in French]. Rev Med Suisse. 2018, 14:1829-33.","journal-title":"Rev Med Suisse"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann M","year":"2016","unstructured":"Ahlmann M, Hempel G. The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol. 2016, 78:661-71. 10.1007\/s00280-016-3152-1","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i39.8844","article-title":"Cyclophosphamide-associated enteritis: a rare association with severe enteritis","volume":"22","author":"Yang LS","year":"2016","unstructured":"Yang LS, Cameron K, Papaluca T, et al.. Cyclophosphamide-associated enteritis: a rare association with severe enteritis. World J Gastroenterol. 2016, 22:8844-8. 10.3748\/wjg.v22.i39.8844","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i20.2657","article-title":"Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: a case report","volume":"27","author":"Sato H","year":"2021","unstructured":"Sato H, Shirai T, Fujii H, Ishii T, Harigae H. Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: a case report. World J Gastroenterol. 2021, 27:2657-63. 10.3748\/wjg.v27.i20.2657","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0434-22","article-title":"Severe enteritis after cyclophosphamide administration in a patient with microscopic polyangiitis: a case report and literature review","volume":"62","author":"Yoshida S","year":"2023","unstructured":"Yoshida S, Temmoku J, Asano T, et al.. Severe enteritis after cyclophosphamide administration in a patient with microscopic polyangiitis: a case report and literature review. Intern Med. 2023, 62:1279-85. 10.2169\/internalmedicine.0434-22","journal-title":"Intern Med"},{"key":"ref12","article-title":"Hemorrhagic colitis as a complication of treatment with cyclophosphamide","volume":"49","author":"Bujakowska O","year":"2011","unstructured":"Bujakowska O, Kur-Zalewska J, T\u0142ustochowicz W. Hemorrhagic colitis as a complication of treatment with cyclophosphamide. Rheumatology. 2011, 49:275-8.","journal-title":"Rheumatology"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical applications","volume":"5","author":"Colvin OM","year":"1999","unstructured":"Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des. 1999, 5:555-60.","journal-title":"Curr Pharm Des"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi A","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009, 6:638-47. 10.1038\/nrclinonc.2009.146","journal-title":"Nat Rev Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2014.14030","article-title":"Cyclophosphamide: as bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases","volume":"144","author":"Dan D","year":"2014","unstructured":"Dan D, Fischer R, Adler S, F\u00f6rger F, Villiger PM. Cyclophosphamide: as bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases. Swiss Med Wkly. 2014, 144:14030. 10.4414\/smw.2014.14030","journal-title":"Swiss Med Wkly"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/096120339700600307","article-title":"Side-effects of intravenous cyclophosphamide pulse therapy","volume":"6","author":"Martin F","year":"1997","unstructured":"Martin F, Lauwerys B, Lef\u00e8bvre C, Devogelaer JP, Houssiau FA. Side-effects of intravenous cyclophosphamide pulse therapy. Lupus. 1997, 6:254-7. 10.1177\/096120339700600307","journal-title":"Lupus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud S","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, et al.. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013, 342:971-6. 10.1126\/science.1240537","journal-title":"Science"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344480-life-threatening-haemorrhagic-enterocolitis-a-rare-complication-of-chemotherapy-with-cyclophosphamide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:03:01Z","timestamp":1740380581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344480-life-threatening-haemorrhagic-enterocolitis-a-rare-complication-of-chemotherapy-with-cyclophosphamide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.79534","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}